why choose us

First received: February 03, 2023

Clinical Trial: The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Paroxysmal Supraventricular Tachycardia

Study Type: INTERVENTIONAL


Official Title: The NODE-202 Study Multi-Center, Multi-National, Open-Label, Efficacy and Safety Study of Etripamil Nasal Spray in Pediatric Patients With Paroxysmal Supraventricular Tachycardia

Brief Summary: NODE-202 is a Phase 2, multicenter, multinational, single dose, open-label, 2-part, sequential design study in pediatric patients with an established diagnosis of paroxysmal supraventricular tachycardia (PSVT) presenting with a symptomatic episode of PSVT.In Part 1, at least 30 patients aged 12 to <18 years will be enrolled and treated with etripamil nasal spray (NS).Efficacy, safety, tolerability and PK (for at least 12 patients) will be assessed after administration of 70 mg etripamil NS (Part 1A).At least 18…

Read more